SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Balk L) "

Search: WFRF:(Balk L)

  • Result 1-10 of 14
Sort/group result
   
EnumerationReferenceCoverFind
1.
  •  
2.
  • Fallarino, L., et al. (author)
  • Magnetic properties of epitaxial CoCr films with depth-dependent exchange-coupling profiles
  • 2017
  • In: Physical Review B. - 2469-9950. ; 95:13
  • Journal article (peer-reviewed)abstract
    • We present a study of the compositional and temperature-dependent magnetic properties of epitaxial CoCr thin films whose composition has a bathtublike depth profile Co/Co1 -> 1- xcCr0 -> xc/Co1-xcCrxc/Co1-xc -> 1Crxc -> 0/Co with the highest Cr concentration (x(c)) at the center of the sample. Polarized neutron reflectometry (PNR) shows that the effective Curie temperature varies as a function of depth and exhibits a minimum in the center of the structure. Correspondingly, we observe that the effective coupling between the two outer Co layers is strongly dependent on the magnetization of the graded CoCr spacer and can be continuously tuned via xc and temperature T. In particular, for x(c) = 0.28, magnetometry reveals a transition from one-step to two-step reversal behavior for temperatures T > 260 K, indicating a transition from a fully correlated magnetic film structure to an uncoupled system containing effectively two independent magnetic sublayers. Corroborating evidence of the temperature- dependent coupling of the top and bottom regions for x(c) = 0.28 was revealed by PNR, which demonstrated the field-dependent occurrence of antiparallel magnetization alignment on opposite interfaces at sufficiently high temperatures only.
  •  
3.
  •  
4.
  • Joosen, R.V.L., et al. (author)
  • Correlating gene expression to physiological parameters and environmental conditions during cold acclimation of Pinus sylvestris, identification of molecular markers using cDNA microarrays
  • 2006
  • In: Tree Physiology. - : Oxford University Press (OUP). - 0829-318X .- 1758-4469. ; 26:10, s. 1297-1313
  • Journal article (peer-reviewed)abstract
    • Scots pine (Pinus sylvestris L.) seedlings were grown under different conditions (three field locations, two seasons and two climate room regimes), and then analyzed for freezing tolerance of shoots and roots and for transcript abundance in apical buds based on a cDNA microarray containing about 1500 expressed sequence tags (ESTs) from buds of cold-treated Scots pine seedlings. In a climate room providing long daily photoperiods and high temperatures, seedlings did not develop freezing tolerance, whereas seedlings in a climate room set to provide declining temperatures and day lengths developed moderate freezing tolerance. Control seedlings grown outside under field conditions developed full freezing tolerance. Differences in physiological behavior of the different seedling groups, combined with molecular analysis, allowed identification of a large group of genes, expression of which changed during the development of freezing tolerance. Transcript abundance of several of these genes was highly correlated with freezing tolerance in seedlings differing in provenance, field location or age, making them excellent candidate marker genes for molecular tests for freezing tolerance.
  •  
5.
  • Bardiene, J., et al. (author)
  • Environmental mutagenesis in different zones of the Baltic Sea
  • 2005
  • In: Acta Zoologica Lituanica. - 1392-1657. ; 15:2, s. 90-95
  • Journal article (peer-reviewed)abstract
    • Abstract. Environmental mutagenesis was assessed in fish from the selected coastal areas of the Baltic SeaKvadofjarden and the Stockholm archipelago (Sweden), the KlaipëdaBûtingë zone (Lithuania), the Gulf of Gdansk (Poland) and the Wismar Bay (Germany). The frequency of micronuclei, as markers of cytogenetic damage, was evaluated in erythrocytes of 911 flounder (Platichthys flesus), 332 perch (Perca fluviatilis) and 458 eelpout (Zoarces viviparus) specimens. Fish was collected during bi-annual sampling campaigns performed in 2001 and 2002. Statistically significant differences (p < 0.0001) regarding season and sampling location were recorded. The highest values of cytogenetic damage were registered in flounder from the Lithuanian coast near Palanga (autumn 2001) and from the Wismar Bay (spring 2001), in perch from the Lithuanian coast near Nemirseta (autumn 2001) and in eelpout from the Wismar Bay (autumn 2001). These values are 510-fold higher than the baseline level of micronucleus incidence. In general, the decrease in environmental mutagenesis was observed in 2002. Nevertheless a significant increase in micronucleus levels was determined in fish after the oil spill in the Bûtingë oil terminal
  •  
6.
  • Gustafsson, Johan, et al. (author)
  • Adult female European perch (Perca fluviatilis) from the Baltic Sea show no evidence of thiamine deficiency
  • 2021
  • In: Journal of Sea Research. - : Elsevier BV. - 1385-1101 .- 1873-1414. ; 174
  • Journal article (peer-reviewed)abstract
    • Deficiency of thiamine (vitamin B1) has been demonstrated in several species in the northern hemisphere and is suggested as a cause for declining populations. European perch from the Baltic Sea show negative temporal trends for several health biomarkers and poor recruitment of unknown cause. In this study, thiamine status of perch liver from the Baltic Sea was studied with emphasis on seasonal variation. During spring the thiamine concentration increased, reached a higher level during the summer and then decreased again during autumn. Despite this variation the thiamine concentration was always sufficient in the perch liver. These results indicate that direct thiamine deficiency is an unlikely explanation for the health effects observed in adult female perch from the Baltic Sea.
  •  
7.
  • Hansson, T., et al. (author)
  • Long-term monitoring of the health status of female perch (Perca fluviatilis) in the Baltic Sea shows decreased gonad weight and increased hepatic EROD activity
  • 2006
  • In: Aquatic Toxicology. - : Elsevier BV. - 0166-445X. ; 79:4, s. 341-355
  • Journal article (peer-reviewed)abstract
    • Annual investigations of the health status of female perch (Perca fluviatilis) were performed during 8-13 years in order to detect long-term, large-scale changes in the Baltic Sea. These background data are also meant to be used as baselines in recipient investigations at various point sources in the Baltic Sea. Fish were sampled at three coastal sites in Sweden: two in the Baltic Proper (since 1988) and one in the Bothnian Bay (since 1993). In all, 19 biochemical, physiological and histopathological variables were measured. By reflecting central functions of life, such as red blood cell functions, immune defence, liver function, biotransformation processes, intermediary metabolism, ion balance, and reproduction, the selected variables give a good picture of the health status of the fish. The most important observations were strong trends towards decreased gonadosomatic index (relative gonad size) and increased hepatic EROD activity in female perch in the Baltic Proper. Most of the other variables varied little between the years. The reduced gonad size and the EROD induction indicate that factors in the environment, e.g. the occurrence of pollutants, affect important physiological functions, such as reproduction and biotransformation processes, in fish even in a reference area in the Baltic Proper. It is urgent to make further studies in order to identify which pollutant(s) or other possible cause(s) are responsible for the observed biological effects. (c) 2006 Elsevier B.V. All rights reserved.
  •  
8.
  • Kasiske, Bertram L., et al. (author)
  • KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
  • 2010
  • In: Kidney International. - : Elsevier BV. - 1523-1755 .- 0085-2538. ; 77:4, s. 299-311
  • Journal article (peer-reviewed)abstract
    • The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on the monitoring, management, and treatment of kidney transplant recipients is intended to assist the practitioner caring for adults and children after kidney transplantation. The guideline development process followed an evidence-based approach, and management recommendations are based on systematic reviews of relevant treatment trials. Critical appraisal of the quality of the evidence and the strength of recommendations followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. The guideline makes recommendations for immunosuppression and graft monitoring, as well as prevention and treatment of infection, cardiovascular disease, malignancy, and other complications that are common in kidney transplant recipients, including hematological and bone disorders. Limitations of the evidence, especially the lack of definitive clinical outcome trials, are discussed and suggestions are provided for future research. This summary includes a brief description of methodology and the complete guideline recommendations but does not include the rationale and references for each recommendation, which are published elsewhere. Kidney International (2010) 77, 299-311; doi: 10.1038/ki.2009.377; published online 21 October 2009
  •  
9.
  • Lenzen, M. J., et al. (author)
  • Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure
  • 2005
  • In: European heart journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 26:24, s. 2706-13
  • Journal article (peer-reviewed)abstract
    • AIMS: Surveys on heart failure management suggest under-utilization of life-saving evidence-based treatment. Evidence-based medicine and clinical guidelines are based on the results of randomized controlled trials. Therefore, we investigated how patients who fulfilled the enrolment criteria of randomized trials were treated in real life. METHODS AND RESULTS: We selected three large placebo-controlled trials of patients with chronic heart failure, in which ACE-inhibitors (ACE-Is), beta-blockers, and spironolactone proved to be safe and effective. The major enrolment criteria of trials were identified and applied to patients enrolled in the Euro Heart Survey on Heart Failure to identify the proportion of patients eligible for treatment and also treated appropriately. Of the 10 701 patients who were enrolled in the Euro Heart Survey on Heart Failure, only a small percentage (13%) would have qualified for participation in at least one of the selected trials. Patients who fulfilled enrolment criteria of the identified trials were more likely to be treated with ACE-Is (83% of SOLVD-eligible patients), beta-blockers (54% of MERIT-HF-eligible patients), and aldosterone antagonists (43% of RALES-eligible patients) than trial-ineligible patients. Almost half of SOLVD-eligible patients who were treated with ACE-Is received the target dose as recommended in the guidelines, but only <10% of MERIT-HF eligible patients who were treated with beta-blockers received the target dose. CONCLUSION: ACE-Is are widely utilized but given in lower doses than proven effective in clinical trials. beta-Blockers are underused and given in lower doses to patients who fulfil the enrolment criteria of relevant landmark trials.
  •  
10.
  • Leurs, CE, et al. (author)
  • Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment
  • 2018
  • In: Multiple sclerosis (Houndmills, Basingstoke, England). - : SAGE Publications. - 1477-0970 .- 1352-4585. ; 24:4, s. 472-480
  • Journal article (peer-reviewed)abstract
    • Mitochondrial dysfunction is increasingly recognized as an important feature of multiple sclerosis (MS) pathology and may be relevant for clinical disease progression. However, it is unknown whether mitochondrial DNA (mtDNA) levels in the cerebrospinal fluid (CSF) associate with disease progression and therapeutic response. Objectives: To evaluate whether CSF concentrations of mtDNA in MS patients can serve as a marker of ongoing neuropathology and may be helpful to differentiate between MS disease subtypes. To explore the effect of disease-modifying therapies on mtDNA levels in the CSF. Methods: CSF mtDNA was measured using a digital polymerase chain reaction (PCR) CSF mtDNA in two independent MS cohorts. The cohorts included 92 relapsing-remitting multiple sclerosis (RRMS) patients, 40 progressive multiple sclerosis (PMS) patients (27 secondary progressive and 13 primary progressive), 50 various neurologic disease controls, and 5 healthy controls. Results: Patients with PMS showed a significant increase in CSF mtDNA compared to non-inflammatory neurologic disease controls. Patients with higher T2 lesion volumes and lower normalized brain volumes showed increased concentration of mtDNA. Patients treated with fingolimod had significantly lower mtDNA copy levels at follow-up compared to baseline. Conclusion: Our results showed a non-specific elevation of concentration of mtDNA in PMS patients. mtDNA concentrations respond to fingolimod and may be used to monitor biological effect of this treatment.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 14

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view